“Author Archive”
Stories written by Max Peykar

According to a review of data gathered through a research, diabetic people who suffer from type-2 diabetes are able to lower their blood sugar levels quite effectively through exercise programs. As per the analysis of 47 random clinical trials, researchers found that exercising for longer periods was better than working out intensely, for lowering blood [...]
May 29th, 2011 | Posted in Diabetes News | Read More »

It is known that those who suffer from diabetes do not have enough insulin-producing pancreatic cells. However, researchers from the UCLA’s L Hillblom Islet Research Center have found a way to make other cells within the body to produce insulin. While the current therapy of injecting insulin to control blood glucose levels has not been [...]
May 28th, 2011 | Posted in Diabetes News | Read More »

According to a study by scientists from the University of Cincinnati, there is a high possibility that multiple pregnancies could lead to an increase in the risk of developing diabetes and obesity. Additionally, other complications may arise as well, such as the concentration of plaque in the arteries, which is one of the risk factors [...]
May 27th, 2011 | Posted in Diabetes News | Read More »

A new study has highlighted the medical costs of children versus the medical costs of children suffering from diabetes, in the US. While children not suffering from diabetes have medical costs amounting to $1,468 a year, those kids who are suffering from diabetes are expected to pay $9,000 a year Ann Albright, director of the [...]
May 17th, 2011 | Posted in Diabetes News | Read More »

According to new research, diabetes is associated with a host of cancers including pancreatic cancer. Additionally, the study also indicated that the risk concerned with cancer mortality rate also increases substantially in both men and women. While this increase in risk is seen on a global scale, some cancers such as prostate cancer are seen [...]
May 17th, 2011 | Posted in Diabetes News | Read More »

Researchers at the Georgia Health Sciences University believe that low levels of an inflammation-controlling protein may help children avoid the onset of type 1 diabetes (Juvenile Diabetes). The researchers are analyzing the blood levels of what is known as interleukin-1 receptor antagonist (IL-1ra). A study conducted on mice that lack IL-1ra looks to see how [...]
May 14th, 2011 | Posted in Diabetes News | Read More »

A study that was conducted in Lagos has revealed how diabetics are not aware of what type of footwear they should be wearing. As per Stephen Ogedengbe, MD, a researcher at the University of Benin Teaching Hospital in Benin City, Nigeria, 41 patients, who were on average about 57 years of age, with type 2 [...]
May 13th, 2011 | Posted in Diabetes News | Read More »

Medical experts from Hackensack University Medical Center are searching for a diabetes cure along with the assistance of some of the world’s leading researchers. The hospital in collaboration with Dr. Camillo Ricordi, a pioneer in the field of diabetes and the scientific director and chief academy officer of the University of Miami Diabetes Research Institute [...]
May 11th, 2011 | Posted in Introduction To Diabetes | Read More »

According to a study published in the journal Medical Care, it is the mental state (depression) of a diabetic patient that doctors should first address. This is the outcome of a one-year program that began with patients receiving behavioral therapy sessions via telephone and an exercise program that focused on walking. As per the study, [...]
May 11th, 2011 | Posted in Diabetes News | Read More »

According to a new study, there are a third of children with diabetes type 1 that show symptoms of other immune system disorders. Type 1 diabetes is where the body mistakes its own pancreas as being foreign and releases antibodies to destroy it. Medical experts have been aware that those affected by type 1 diabetes [...]
May 7th, 2011 | Posted in Diabetes News | Read More »

Eli Lilly and Company along with Amylin Pharmaceuticals, Inc. and Alkermes, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a favorable recommendation for exenatide 2 mg powder and solvent, which is to be known as BYDUREON, for treatment of type 2 diabetes. BYDUREON [...]
May 5th, 2011 | Posted in Diabetes News | Read More »